Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium

被引:84
|
作者
Ioffe, OB [1 ]
Papadimitriou, JC [1 ]
Drachenberg, CB [1 ]
机构
[1] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
关键词
cell death; endometrial adenocarcinoma; proliferative activity; oncogene expression; bcl-2;
D O I
10.1016/S0046-8177(98)90429-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: The various morphological groupings of endometrial pathology are often difficult to distinguish from each other. The endometrium is an actively proliferating tissue and there is an overlap in cell proliferation fraction (CPF) between benign proliferative endometrium (BPE) and endometrial carcinoma (EC). Apoptosis in benign cycling endometrium is related to the menstrual cycle. In this study we evaluated CPF, apoptosis, and oncogenes that relate to cell turnover (bcl-2, p53, and c-erbB-2) in the spectrum of endometrial pathology. Methods: We examined a total of 64 cases consisting of 10 cases of BPE, 18 cases of simple endometrial hyperplasia (SEH), 18 cases of complex hyperplasia (CEH; including eight cases with atypical hyperplasia), and 18 cases of EC, FIGO grade 1. CPF was measured by the mitotic index (hll) and by the percentage of Ki-67 positive nuclei (Ki-67 index). Apoptotic index (AI) was determined on hematoxylin and eosin sections. Results: MI was 2.48% in BPE, 0.65% in SEH, 0.6% in CEH, and 0.91% in EC (P < .00001). Ki-67 index was 38.44%, 16.4%, 23.25%, and 31.7% respectively (P < .00001). AI was 1.17%, 2.2%, 2.57%, and 3.31% respectively (P = .02). The AI/MI and Al/Ki-67 ratios were lowest in BPE and highest in SEH (P = .007). All cases of BPE, 84% of SEH cases, 77% of CEH cases, and 88% of EC cases displayed cytoplasmic and/or nuclear bcl-2 expression. Cytoplasmic bcl-2 expression increased from BPE to SEH, whereas it decreased in CEH and EC with emergence of only nuclear expression. Of the EC cases, 38.8% showed intense nuclear bcl-2 reactivity and a significantly higher Ki-67 index than cases with ectoplasmic expression (P = .01). No p53 or c-erbB-2 expression was seen in either BPE or EH. Of the EC cases, 50% were positive for p53 whereas 30% were positive for c-erbB-2. C-erbB-2-positive cases had a significantly higher Ki-67 index: and AI than negative cases (P = .02). Cases of EC with p53 expression also had significantly higher AI (P = .01). Conclusions: In actively proliferating tissues like endometrium, CPF does not correlate with progression to malignancy In contrast, AI and derived AI/CPF ratios are better indicators of progression. The expression of p53, c-erbB-2, and nuclear bcl-2 in EC correlate with higher cell turnover indices (CPI; and Al). Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:1150 / 1159
页数:10
相关论文
共 50 条
  • [1] Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium
    Cinel, L
    Polat, A
    Aydin, Ö
    Düsmez, D
    Egilmez, R
    [J]. PATHOLOGY INTERNATIONAL, 2002, 52 (5-6) : 384 - 389
  • [2] Expression of Bcl-2 and p53 in the normal, hyperplastic and malignant endometrium.
    Rasty, G
    Lu, L
    Masood, S
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 558 - 558
  • [3] Immunohistochemical expression of Bcl-2 protein in breast lesions: Correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices
    Ioachim, EE
    Malamou-Mitsi, V
    Kamina, SA
    Goussia, AC
    Agnantis, NJ
    [J]. ANTICANCER RESEARCH, 2000, 20 (6B) : 4221 - 4225
  • [4] c-erbB-2 expression in human proliferative and hyperplastic endometrium
    Miturski, R
    Semczuk, A
    Jakowicki, JA
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1998, 61 (01) : 73 - 74
  • [5] Immunohistochemical evaluation of cathepsin D in normal, hyperplastic and malignant endometrium: Correlation with hormone receptor status c-erbB-2, p53, Rb proteins and proliferation associated indices
    Ioachim, E
    Kitsiou, E
    Charalabopoulos, K
    Mitselou, A
    Zagorianakou, N
    Makrydimas, G
    Tzioras, S
    Salmas, M
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (03) : 344 - 351
  • [6] Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas
    de Krijger, RR
    van der Harst, E
    van der Ham, F
    Stijnen, T
    Dinjens, WNM
    Koper, JW
    Bruining, HA
    Lamberts, SWJ
    Bosman, FT
    [J]. JOURNAL OF PATHOLOGY, 1999, 188 (01): : 51 - 55
  • [7] Immunohistochemical expression of Retinoblastoma gene product in normal, hyperplastic and malignant endometrium. Correlation with p53 protein expression, c-erbB-2, hormone receptors' status and proliferative activity
    Ioachim, EE
    Goussia, AC
    Kitsiou, EG
    Charalabopoulos, K
    Mermiga, E
    Stefanaki, S
    [J]. DISEASE MARKERS, 2002, 18 (03) : 143 - 152
  • [8] Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium
    Mitselou, A
    Ioachim, E
    Kitsou, E
    Vougiouklakis, T
    Zagorianakou, N
    Makrydimas, G
    Stefanaki, S
    Agnantis, NJ
    [J]. IN VIVO, 2003, 17 (05): : 469 - 477
  • [9] The effect of isochromosome 17q presence, proliferative and apoptotic indices, expression of c-erbB-2, bcl-2 and p53 proteins on the prognosis of medulloblastoma
    Nam, DH
    Wang, KC
    Kim, YM
    Chi, JG
    Kim, SK
    Cho, BK
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2000, 15 (04) : 452 - 456
  • [10] Immunohistochemical evaluation of Cathepsin D expression in colorectal tumours: A correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices
    Ioachim, EE
    Goussia, AC
    Machera, M
    Tsianos, EV
    Kappas, AM
    Agnantis, NJ
    [J]. ANTICANCER RESEARCH, 1999, 19 (3A) : 2147 - 2155